https://stock.noler.com/us/stock/cidara-therapeutics-inc https://stock.noler.com/us/stock/cidara-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/cidara-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/cidara-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/cidara-therapeutics-inc/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/cidara-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/cidara-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/cidara-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/cidara-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/cidara-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/cidara-therapeutics-inc/aoci https://stock.noler.com/us/stock/cidara-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/cidara-therapeutics-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-gain-loss https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/cidara-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/cidara-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/cidara-therapeutics-inc/buybacks-payments-for-repurchase-of-equity https://stock.noler.com/us/stock/cidara-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/cidara-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/cidara-therapeutics-inc/capitalized-contract-cost-amortization https://stock.noler.com/us/stock/cidara-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/cidara-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/cidara-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/cidara-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/cidara-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/cidara-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/cidara-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/cidara-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/cidara-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/cidara-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/cidara-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/cidara-therapeutics-inc/current-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/cidara-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/cidara-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/cidara-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-liabilities-deferred-expense-other-capitalized-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/cidara-therapeutics-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/cidara-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/derivative-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/cidara-therapeutics-inc/discontinued-operation-tax-effect-of-discontinued-operation https://stock.noler.com/us/stock/cidara-therapeutics-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/cidara-therapeutics-inc/dividends-preferred-stock https://stock.noler.com/us/stock/cidara-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/cidara-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/eps https://stock.noler.com/us/stock/cidara-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-right-of-use-asset-accumulated-amortization https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/cidara-therapeutics-inc/finance-lease-right-of-use-asset-before-accumulated-amortization https://stock.noler.com/us/stock/cidara-therapeutics-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/cidara-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/cidara-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/cidara-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/cidara-therapeutics-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/cidara-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/cidara-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/cidara-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/cidara-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/cidara-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/cidara-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/cidara-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/cidara-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/cidara-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/cidara-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/cidara-therapeutics-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/cidara-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/cidara-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/cidara-therapeutics-inc/inventory https://stock.noler.com/us/stock/cidara-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/cidara-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/cidara-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/cidara-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/cidara-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/cidara-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/lessee-finance-lease-discount-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/cidara-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/cidara-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/cidara-therapeutics-inc/loans-payable https://stock.noler.com/us/stock/cidara-therapeutics-inc/loans-payable-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/long-term-loans-payable https://stock.noler.com/us/stock/cidara-therapeutics-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/cidara-therapeutics-inc/maturities-of-shortterm-investments https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-income https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/cidara-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/cidara-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/cidara-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/cidara-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/cidara-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-income https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-income https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-than-temporary-impairment-loss-debt-securities-available-for-sale https://stock.noler.com/us/stock/cidara-therapeutics-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/cidara-therapeutics-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/cidara-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/cidara-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/cidara-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/cidara-therapeutics-inc/participating-securities-distributed-and-undistributed-earnings-loss-basic https://stock.noler.com/us/stock/cidara-therapeutics-inc/participating-securities-distributed-and-undistributed-earnings-loss-diluted https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-for-proceeds-from-short-term-investments https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-for-repurchase-of-initial-public-offering https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/cidara-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/cidara-therapeutics-inc/pending-claims-number https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/cidara-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/cidara-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/cidara-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/cidara-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/cidara-therapeutics-inc/public-float https://stock.noler.com/us/stock/cidara-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/cidara-therapeutics-inc/research-and-development-in-process https://stock.noler.com/us/stock/cidara-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/cidara-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/restricted-cash-current https://stock.noler.com/us/stock/cidara-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/cidara-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/cidara-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/cidara-therapeutics-inc/revenue https://stock.noler.com/us/stock/cidara-therapeutics-inc/revenue-from-collaborative-arrangement-excluding-revenue-from-contract-with-customer https://stock.noler.com/us/stock/cidara-therapeutics-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/cidara-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/cidara-therapeutics-inc/sale-of-stock-consideration-received-per-transaction https://stock.noler.com/us/stock/cidara-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/cidara-therapeutics-inc/severance-costs https://stock.noler.com/us/stock/cidara-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/share-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/cidara-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/cidara-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/cidara-therapeutics-inc/shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/cidara-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/cidara-therapeutics-inc/straight-line-rent https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-cuts-and-jobs-act-incomplete-accounting-provisional-income-tax-expense-benefit https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-rate-reconciliation-tax-cuts-and-jobs-act-amount https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/cidara-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/cidara-therapeutics-inc/total-assets https://stock.noler.com/us/stock/cidara-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/cidara-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/cidara-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/cidara-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-diluted https://stock.noler.com/us/stock/cidara-therapeutics-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/cidara-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/cidara-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/cidara-therapeutics-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/cidara-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/cidara-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/cidara-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/cidara-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/cidara-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/cidara-therapeutics-inc/weighted-average-number-of-shares-issued-basic